id peroxide production. 14 Phosphatidylcholine is an important lipid in the cellular membrane and is a major structural constituent of tissue lipids. 11 Phosphatidylcholine hydroperoxide is formed by the reaction of reactive oxygen species with phosphatidylcholine. Cholesteryl ester hydroperoxide is the most abundant lipid peroxide present in vivo, 2, 18 and is formed from cholesteryl ester by exposure to oxidative stress. 5 Therefore, the determination of levels of PCOOH and CEOOH seems to be important for the assessment of the degree of membrane lipid damage by reactive oxygen species. Unlike other parts of the body, CSF is almost completely lacking in defense mechanisms against free radicals. When such free radical reactions are provoked in the subarachnoid space after SAH, it is suspected that this cascade must cause functional or structural damage in the arterial wall, resulting in cerebral vasospasm.
Our objectives in this study were to determine whether lipid peroxides, including PCOOH and CEOOH, are detectable in the CSF as biochemical markers of free radical damage in patients with SAH, and to correlate the levels of PCOOH and CEOOH in the CSF with the occurrence of symptomatic vasospasm and clinical outcome.
Clinical Material and Methods

Patient Population
Twenty patients with SAH, who were treated surgically within 24 hours after onset of the hemorrhage, were included in this study. There were six men and 14 women, with a mean age of 55.5 Ϯ 12.9 years (range 26-80 years). Patients were graded clinically according to the Hunt and Hess scale 7 (one patient was Grade I, eight were Grade II, seven were Grade III, and four patients were Grade IV). Patients were also graded radiographically according to the Fisher scale 5 (one patient was Group 1, none was Group 2, 14 were Group 3, and five patients were Group 4). Eighteen patients (90%) harbored aneurysms in the anterior circulation, whereas two patients (10%) harbored aneurysms in the posterior circulation. In all cases, microsurgical clipping for ruptured cerebral aneurysm was performed and a spinal drainage tube was placed. Continuous spinal drainage was discontinued on Day 7 post-SAH. Five milliliters CSF from the spinal drain was collected within 48 hours after onset of SAH and on Day 6 or 7 posthemorrhage. All samples were stored at Ϫ80˚C until measurement of PCOOH and CEOOH.
The neurological status of each patient was evaluated daily. Flow velocities in the M 1 portion of the middle cerebral artery were measured daily by using transcranial Doppler ultrasonography in selected patients. On Day 7 post-SAH, a second angiogram was routinely obtained and patients were then classified into the following groups: 1) symptomatic vasospasm, if a reduction in vessel diameter observed angiographically was greater than 50% and was accompanied by a contralateral weakness in the motor areas supplied by the middle cerebral artery or if global neurological deterioration occurred after Day 3, indicating anterior or diffuse vasospasm; 2) angiographic vasospasm, if the angiogram displayed a 25% reduction in the baseline vessel diameter without clinical deterioration; or 3) no vasospasm, if there was no significant reduction in vessel diameter that was observed angiographically. Angiograms were carefully examined by at least three neurosurgeons to minimize observational errors. Patients with symptomatic vasospasm were maintained in a hyperdynamic state by induction of hypertension, hypervolemia, and hemodilution.
We investigated the relationships between levels of PCOOH and CEOOH in the CSF and clinical profiles such as patient age, sex, Hunt and Hess grade on admission, Fisher group, location of the aneurysm, angiographic findings, and clinical outcome at 3 months as assessed using the GOS. 8 
Measurement of PCOOH and CEOOH
Total lipids in the CSF were extracted essentially according to the method of Bligh and Dyer 1 by using a mixture of chloroform and methanol (1:2 vol/vol) containing butylated hydroxytoluene as an antioxidant. The extracts dissolved in methanol were stored at Ϫ80˚C until the time of measurement. Measurement of lipid peroxides was performed as previously described. 6 In brief, PCOOH and CEOOH were separated by reverse-phase high-performance liquid chromatography while using a methanol/water ratio of 95:5 (vol/vol) as the mobile phase and while detected by an ultraviolet light detector at 235 nm. The peaks were confirmed with the aid of a chemiluminescence detector connected to the ultraviolet light detector after addition of luminol and cytochrome c. 16 The quantitative determination of levels of PCOOH and CEOOH was performed using synthesized standards according to the method of Terao, et al. 16, 17 
Statistical Analysis
All values are expressed as means Ϯ standard deviations. Data within each group were compared using analysis of variance for continuous variables and, if significant, a Fisher protected least significant difference test was performed. A comparison of discrete variables was performed using the chi-square test with the Yates rectification. For chi-square analysis patient outcomes were reclassified into two groups: a good outcome group (good recovery and moderate disability according to the GOS) and a poor outcome group (severe disability, persistent vegetative state, and death as defined by the GOS). The amount of subarachnoid clot was also reclassified into two groups according to the Fisher grade: a diffuse or thick hematoma group and a local or thin hematoma group. Differences were considered significant if the probability level was less than 0.05.
Results
Clinical Profiles
Microsurgical clipping for ruptured aneurysms was performed successfully in all cases. No patient exhibited signs of severe cardiac insufficiency, concomitant infection, or acute or chronic renal failure throughout the clinical course. The overall incidence of angiographic vasospasm was 65% (13 patients), with symptomatic vasospasm occurring in 40% (eight patients). The median onset of neurological deterioration related to vasospasm occurred 6.3 days post-SAH (range 4-7 days posthemorrhage). The mean followup period was 301.7 Ϯ 188.9 days (range 14-598 days). Clinical outcomes were as follows: good recovery in seven patients; moderate disability in three; severe disability in six; persistent vegetative state in two; and death in two patients.
There was no significant correlation between the occurrence of symptomatic vasospasm and patient age (p = 0.1532), sex (p = 0.1632), Hunt and Hess grade on admission (p = 0.2102), or location of the aneurysm (p = 0.4821). There was a tendency for larger amounts of hematoma, according to the definition of the Fisher grading system, to be associated with the occurrence of symptomatic vasospasm, but it did not reach significance (p = 0.2023). There was also no significant correlation between clinical outcome and patient age (p = 0.8692), sex (p = 0.2165), or location of the aneurysm (p = 0.756). There was a trend for higher Hunt and Hess grades to be associated with poor outcomes, but this did not reach significance (p = 0.095).
Levels of CEOOH and PCOOH in the CSF
The mean levels of PCOOH and CEOOH in the CSF within 48 hours after onset of hemorrhage were 0.25 Ϯ 0.4 and 0.19 Ϯ 0.34 nmol/ml, respectively. The CSF level of each lipid peroxide showed a rapid reduction within 7 days after onset of hemorrhage: the mean level of PCOOH was 0.04 Ϯ 0.03 nmol/ml, and the mean level of CEOOH was 0.02 Ϯ 0.07 nmol/ml. Levels of CEOOH within 48 hours after onset of SAH were 0.337 Ϯ 0.663 nmol/ml in the diffuse and thick hematoma group and 0.168 Ϯ 0.239 nmol/ml in the focal or thin hematoma group. There was a tendency for higher CEOOH levels to be associated with larger amounts of hematoma, but this did not reach significance (p = 0.4634). In contrast, the PCOOH levels within 48 hours after onset of hemorrhage were 0.652 Ϯ 0.715 nmol/ml in the diffuse and thick hematoma group and 0.147 Ϯ 0.199 nmol/ml in the focal or thin hematoma group. The CEOOH levels were significantly higher in patients with larger amounts of hematoma (p = 0.042).
The CEOOH levels within 48 hours after onset of SAH were significantly higher in patients in whom symptomatic vasospasm later developed than in patients in whom no symptomatic vasospasm occurred (p = 0.002) (Fig. 1) . The PCOOH levels within 48 hours after SAH onset were significantly higher in patients with poor outcomes (p = 0.043) (Fig. 2) . Both PCOOH and CEOOH levels within 48 hours after onset of hemorrhage did not correlate with the occurrence of angiographic vasospasm. Both PCOOH and CEOOH levels on Day 6 or 7 post-SAH were low, and there were no significant differences between their levels and the occurrence of symptomatic vasospasm or clinical outcome.
To determine the relationship between the findings of transcranial Doppler ultrasonography and the levels of lipid peroxides seemed important, but the lack of several data prevented us from performing this analysis.
Discussion
Delayed cerebral vasospasm is associated with high rates of morbidity and mortality, even after an aneurysm has been secured surgically or radiologically. A great deal of experimental and clinical research has been conducted in an effort to find ways to prevent this complication. Early detection and rapid treatment of delayed cerebral vasospasm are needed, before ischemic damage occurs. Nevertheless, detection is sometimes too late for treatment to be helpful. The results of our study clearly demonstrate that increased levels of lipid peroxides in the CSF during the acute stage of SAH are predictive of symptomatic vasospasm and poor outcome. Fisher grading has been used for evaluating the amount of the subarachnoid clot and for predicting the occurrence of vasospasm. 5 In this study, there was a tendency for higher levels of lipid peroxides to be associated with larger amounts of hematoma, and measurements of CEOOH predicted the occurrence of symptomatic vasospasm more accurately than Fisher grade. The levels of CEOOH in the CSF during the acute stage of SAH can be used as the predictor of symptomatic vasospasm. The level of PCOOH present in the CSF may be a reflection of neuronal tissue damage, rather than a direct contributor to vasospasm. Although statistically, an elevated level of CEOOH was associated with symptomatic vasospasm it was not associated with poor outcome; the opposite was true for PCOOH. These two lipid peroxides showed the same tendency for predicting the occurrence of vasospasm and outcome ( Figs. 1 and 2 ). Additional investigations are essential to determine the specific role of CEOOH and PCOOH in a larger sample size, and to obtain a more appropriate statistical model such as a logistic regression.
The mechanism of vasospasm after SAH remains to be fully delineated, but there are likely contributions by multiple factors. 4, 13 Among them are free radical reactions triggered by oxyhemoglobin released from the subarachnoid clot and subsequent lipid peroxidation, which may participate in the pathogenesis of cerebral vasospasm. 13, 15 These chain reactions cause both an augmentation of contraction and suppression of vessel dilation. 19 Phosphatidylcholine and cholesteryl ester are very important functional components of biological membranes, and are also major structural constituents in tissue lipids. 2 Lipid peroxides such as PCOOH and CEOOH are both products of free radical ox- hours after onset of SAH in patients with poor outcomes is significantly higher (asterisk) than that in patients with good outcomes (p = 0.043). There is a tendency for higher levels of CEOOH to be associated with poor outcomes.
idation of such fatty acids and major substrates for starting the chain-reaction production of free radicals. Suzuki, et al., 15 measured PCOOH levels in the cerebral arteries and cerebral tissues obtained from a primate model of SAH. They found that PCOOH levels in cerebral arteries that display vasospasm are significantly higher than those measured in arteries in which no contraction is evident. The levels of PCOOH in the brain tissue in contact with the subarachnoid clot were five times higher than those measured in other regions. 15 Nevertheless, there was no significant difference in the values of the clots. These data support our findings that PCOOH levels in the CSF did not predict the occurrence of symptomatic vasospasm. Polidori, et al., 12 measured plasma levels of CEOOH in patients with SAH. They found that plasma CEOOH levels paralleled the persistence of vasospasm, but were not predictive of symptomatic vasospasm. We measured levels of lipid peroxides in the CSF, where free radical reactions and vasospasm occur. A spinal or cisternal tube is commonly placed in the patient for treatment of SAH to drain the subarachnoid clot and to obtain CSF easily. By analyzing CSF, rather than plasma, such chain reactions can be more directly and promptly estimated. Observing temporal changes in these lipid peroxides in the CSF was also important. In addition, it seems essential to obtain control values of these lipid peroxides in the CSF from healthy volunteers for a better understanding of the role of these agents. Our results, however, indicate that measurement of lipid peroxides during the acute stage of SAH could be a good screening tool to predict which patients are at risk for the development of vasospasm and/ or having a poor outcome. Patients with high levels of lipid peroxides in the CSF could, therefore, be treated aggressively.
The use of free radical scavengers in preventing vasospasm in clinical practice has been universally disappointing. Nevertheless, Kodama, et al., 10 reported that cisternal irrigation with ascorbic acid effectively prevented vasospasm. Our data clearly indicate that lipid peroxidation by free radicals occurs in the CSF and, therefore, if water-soluble free radical scavengers were administered intrathecally, as Kodama did with ascorbate, they could exhibit their maximum protective effect. Further studies in larger patient cohorts are required to rule in or out definitively the role of lipid peroxides in the pathogenesis of this important complication of SAH.
